[go: up one dir, main page]

GB0808956D0 - biological materials and uses thereof - Google Patents

biological materials and uses thereof

Info

Publication number
GB0808956D0
GB0808956D0 GBGB0808956.7A GB0808956A GB0808956D0 GB 0808956 D0 GB0808956 D0 GB 0808956D0 GB 0808956 A GB0808956 A GB 0808956A GB 0808956 D0 GB0808956 D0 GB 0808956D0
Authority
GB
United Kingdom
Prior art keywords
biological materials
biological
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB0808956.7A
Other versions
GB2460086A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Antisoma Research Ltd
Original Assignee
Antisoma Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Antisoma Research Ltd filed Critical Antisoma Research Ltd
Priority to GB0808956A priority Critical patent/GB2460086A/en
Publication of GB0808956D0 publication Critical patent/GB0808956D0/en
Priority to PCT/GB2009/000326 priority patent/WO2009098464A2/en
Priority to US12/866,102 priority patent/US20110105422A1/en
Priority to JP2010545549A priority patent/JP2011511051A/en
Priority to EP09707136A priority patent/EP2268284A2/en
Publication of GB2460086A publication Critical patent/GB2460086A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
    • C12N2310/151—Nucleic acids forming more than 2 strands, e.g. TFOs more than 3 strands, e.g. tetrads, H-DNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/17—Immunomodulatory nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/31—Chemical structure of the backbone
    • C12N2310/315—Phosphorothioates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/32—Chemical structure of the sugar
    • C12N2310/321—2'-O-R Modification

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB0808956A 2008-02-05 2008-05-16 Treatment of paediatric cancers Withdrawn GB2460086A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB0808956A GB2460086A (en) 2008-05-16 2008-05-16 Treatment of paediatric cancers
PCT/GB2009/000326 WO2009098464A2 (en) 2008-02-05 2009-02-05 Biological materials and uses thereof
US12/866,102 US20110105422A1 (en) 2008-02-05 2009-02-05 Use of g-rich oligonucleotides for treating neoplastic diseases
JP2010545549A JP2011511051A (en) 2008-02-05 2009-02-05 Biological substances and their use
EP09707136A EP2268284A2 (en) 2008-02-05 2009-02-05 Use of g-rich oligonucleotides for treating neoplastic diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0808956A GB2460086A (en) 2008-05-16 2008-05-16 Treatment of paediatric cancers

Publications (2)

Publication Number Publication Date
GB0808956D0 true GB0808956D0 (en) 2008-06-25
GB2460086A GB2460086A (en) 2009-11-18

Family

ID=39596034

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0808956A Withdrawn GB2460086A (en) 2008-02-05 2008-05-16 Treatment of paediatric cancers

Country Status (1)

Country Link
GB (1) GB2460086A (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU775412B2 (en) * 1999-04-08 2004-07-29 Advanced Cancer Therapeutics, Inc. Antiproliferative activity of G-rich oligonucleotides and method of using same to bind to nucleolin

Also Published As

Publication number Publication date
GB2460086A (en) 2009-11-18

Similar Documents

Publication Publication Date Title
HRP20180718T1 (en) Oligopeptidic compounds and uses thereof
HK1150614A1 (en) Biological materials and uses thereof
IL210804A (en) Benzylidenehydrazides and uses thereof
IL209309A0 (en) Anti-fn14 antibodies and uses thereof
IL216731A (en) P95-her2 antibodies and uses thereof
GB0904825D0 (en) Biological materials and uses thereof
HK1199888A1 (en) Biological materials and uses thereof
ZA201103456B (en) Leukolectins and uses thereof
EP2291377A4 (en) Imidazopyrimidinones and uses thereof
HK1210026A1 (en) Thiol-functionalising reagents and their uses
EP2247601A4 (en) Thiazopyrimidinones and uses thereof
GB0701062D0 (en) Biological materials and uses thereof
GB0811362D0 (en) Biological materials and uses thereof
GB0606269D0 (en) Biological materials and uses thereof
GB0802980D0 (en) Biological materials and uses thereof
GB0812277D0 (en) Antibody and uses thereof
GB0922143D0 (en) Biological materials and uses thereof
GB0617241D0 (en) Biological materials and uses thereof
GB0802075D0 (en) Biological materials and uses thereof
GB0808956D0 (en) biological materials and uses thereof
GB0718781D0 (en) Biological materials and uses thereof
GB0711926D0 (en) Biological materials and uses thereof
GB0708001D0 (en) Biological materials and uses thereof
GB0606268D0 (en) Biological materials and uses thereof
GB0625264D0 (en) Biological materials and uses thereof

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)